Gene editing technology to improve antitumor T-cell functions in adoptive immunotherapy
Abstract Adoptive immunotherapy, in which tumor-reactive T cells are prepared in vitro for adoptive transfer to the patient, can induce an objective clinical response in specific types of cancer. In particular, chimeric antigen receptor (CAR)-redirected T-cell therapy has shown robust responses in h...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2024-03-01
|
| Col·lecció: | Inflammation and Regeneration |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s41232-024-00324-7 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|